Department of Physiology, McGill University, Montréal, QC, Canada,
Cystic Fibrosis Translational Research Centre, McGill University, Montréal, QC, Canada.
Cell Physiol Biochem. 2021 Dec 23;55(6):784-804. doi: 10.33594/000000477.
BACKGROUND/AIMS: Cystic fibrosis transmembrane conductance regulator (CFTR), the anion channel that is defective in cystic fibrosis (CF), is phosphorylated and activated by cAMP-dependent protein kinase (PKA). cAMP levels are downregulated by a large family of phosphodiesterases that have variable expression in different cell types. We have previously observed high levels of PDE8A expression in well-differentiated primary human bronchial epithelial (pHBE) cells and thus aimed to assess whether it played a role in cAMP-dependent regulation of CFTR activity.
We assessed the effect of the selective PDE8 inhibitor PF-04957325 (PF) on intracellular cAMP levels ([cAMP]) in well differentiated pHBE cells from non-CF or CF donors and also in CFBE41o- cells that stably express wild-type CFTR (CFBE41o- WT) using ELISA and FRET-FLIM microscopy. CFTR channel function was also measured using electrophysiological recordings from pHBE and CFBE41o- WT cells mounted in Ussing Chambers.
PDE8 inhibition elevated [cAMP] in well-differentiated pHBE cells and stimulated wild-type CFTR-dependent ion transport under basal conditions or after cells had been pre-stimulated with physiological cAMP-elevating agents. The response to PDE8 inhibition was larger than to PDE3 or PDE5 inhibition but smaller and synergistic with that elicited by PDE4 inhibition. CRISPR Cas9-mediated knockdown of PDE8A enhanced CFTR gene and protein expression yet reduced the effect of PDE8 inhibition. Acute pharmacological inhibition PDE8 increased CFTR activity in CF pHBE cells (F508del/F508del and F508del/R117H-5T) treated with clinically-approved CFTR modulators.
These results provide the first evidence that PDE8A regulates CFTR and identifies PDE8A as a potential target for adjunct therapies to treat CF.
背景/目的:囊性纤维化跨膜电导调节因子(CFTR)是囊性纤维化(CF)中缺陷的阴离子通道,可被 cAMP 依赖性蛋白激酶(PKA)磷酸化和激活。cAMP 水平受磷酸二酯酶(PDE)家族的下调,该家族在不同细胞类型中的表达不同。我们之前观察到在分化良好的原代人支气管上皮(pHBE)细胞中 PDE8A 的高表达水平,因此旨在评估其是否在 CFTR 活性的 cAMP 依赖性调节中发挥作用。
我们评估了选择性 PDE8 抑制剂 PF-04957325(PF)对来自非 CF 或 CF 供体的分化良好的 pHBE 细胞以及稳定表达野生型 CFTR(CFBE41o-WT)的 CFBE41o-细胞中细胞内 cAMP 水平([cAMP])的影响,使用 ELISA 和 FRET-FLIM 显微镜。还使用 pHBE 和 CFBE41o-WT 细胞在 Ussing 室中进行的电生理记录测量 CFTR 通道功能。
PDE8 抑制在分化良好的 pHBE 细胞中升高了[cAMP],并在基础条件下或在细胞预先用生理升高 cAMP 的激动剂刺激后刺激了野生型 CFTR 依赖性离子转运。对 PDE8 抑制的反应大于对 PDE3 或 PDE5 抑制的反应,但小于并与 PDE4 抑制的反应协同。CRISPR Cas9 介导的 PDE8A 敲低增强了 CFTR 基因和蛋白表达,但降低了 PDE8 抑制的作用。急性药理学抑制 PDE8 增加了用临床批准的 CFTR 调节剂治疗的 CF pHBE 细胞(F508del/F508del 和 F508del/R117H-5T)中 CFTR 的活性。
这些结果首次提供了证据表明 PDE8A 调节 CFTR,并确定 PDE8A 是治疗 CF 的潜在联合治疗靶标。